Haemonetics
270 hedge funds and large institutions have $3.83B invested in Haemonetics in 2022 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 84 increasing their positions, 101 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.5% less ownership
Funds ownership: 101.35% → 100.85% (-0.5%)
9% less call options, than puts
Call options by funds: $4.6M | Put options by funds: $5.08M
17% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 101
Holders
270
Holding in Top 10
3
Calls
$4.6M
Puts
$5.08M
Top Buyers
| 1 | +$30M | |
| 2 | +$17.8M | |
| 3 | +$16.2M | |
| 4 |
Neuberger Berman Group
New York
|
+$12.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8M |
Top Sellers
| 1 | -$46.6M | |
| 2 | -$27.7M | |
| 3 | -$22.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$20.1M |
| 5 |
LCP
LGT Capital Partners
Pfaeffikon,
Switzerland
|
-$16.1M |